Metabolism Des LAM
NCT02176109 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2014-06-26
Summary
In this study, the investigators study the prognostic role of oxidative stress metabolism and iron in Acute myeloid leukemia.
Conditions
- Iron
- Acute Myeloid Leukemia
- Diagnosis
- Oxydative Stress
Sponsors & Collaborators
-
University Hospital, Grenoble
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2015-06-30
- Completion
- 2018-06-30
Countries
- France
Study Locations
More Related Trials
-
Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia
NCT04699162 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
NCT01642121 ·Status: COMPLETED
-
First Report, Five Years Experience of the Acute Leukemia Work Group
NCT02990104 ·Status: UNKNOWN
-
Multicenter Retrospective Observatory of Patients With Acute Myeloid Leukemia to Core Binding Factor
NCT05070208 ·Status: COMPLETED
-
Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy
NCT00896129 ·Status: COMPLETED
-
MIF Involvement in AML
NCT03918655 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia
NCT05499611 ·Status: COMPLETED
-
The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis
NCT02696304 ·Status: UNKNOWN ·Phase: NA
-
Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies
NCT07189117 ·Status: RECRUITING
-
Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation
NCT00219726 ·Status: COMPLETED ·Phase: PHASE2
-
The Patient Cohort of the National Center for Precision Medicine in Leukemia
NCT05326919 ·Status: RECRUITING
-
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
NCT03075969 ·Status: UNKNOWN
-
Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia
NCT06814444 ·Status: RECRUITING
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
NCT05875649 ·Status: NOT_YET_RECRUITING
-
Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
NCT01437202 ·Status: COMPLETED
-
Genotyping Analysis of Acute Lymphoblastic Leukemia
NCT00961285 ·Status: UNKNOWN
-
French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients
NCT05619978 ·Status: COMPLETED
-
Molecular Diagnostic Platform for AML
NCT04446741 ·Status: UNKNOWN
-
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia
NCT01455025 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Metabolism in the Lymphatic Niche of CLL
NCT05610228 ·Status: UNKNOWN
-
French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings
NCT05590702 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of LAM-003 in Patients With Acute Myeloid Leukemia
NCT03426605 ·Status: COMPLETED ·Phase: PHASE1
-
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey
NCT03647215 ·Status: COMPLETED
-
Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
NCT05971251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1